Lu Yue

1.1k total citations
34 papers, 866 citations indexed

About

Lu Yue is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lu Yue has authored 34 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Lu Yue's work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (5 papers) and Peptidase Inhibition and Analysis (4 papers). Lu Yue is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (5 papers) and Peptidase Inhibition and Analysis (4 papers). Lu Yue collaborates with scholars based in China, United States and Hong Kong. Lu Yue's co-authors include Ruyong Yao, Yuanjue Sun, Liwei Wang, Weiyi Huang, Xiaohan Zhou, Wensheng Qiu, Yasai Yao, Fang Zhou, Likun Zhuang and Fei Zhou and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Molecular Therapy.

In The Last Decade

Lu Yue

34 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Yue China 17 627 234 227 119 71 34 866
Ines Koch Germany 13 667 1.1× 288 1.2× 216 1.0× 80 0.7× 57 0.8× 16 1.1k
Youngtae Jeong United States 11 504 0.8× 199 0.9× 190 0.8× 154 1.3× 93 1.3× 20 805
Suihai Wang China 15 482 0.8× 250 1.1× 133 0.6× 74 0.6× 113 1.6× 25 745
Wan-Ju Kim United States 15 559 0.9× 209 0.9× 267 1.2× 112 0.9× 65 0.9× 26 819
Yueling Liao China 16 425 0.7× 206 0.9× 234 1.0× 131 1.1× 121 1.7× 25 710
Hannie Sietsma Netherlands 19 751 1.2× 109 0.5× 282 1.2× 172 1.4× 104 1.5× 22 1.0k
Álvaro Gutiérrez-Uzquiza Spain 14 440 0.7× 101 0.4× 167 0.7× 80 0.7× 74 1.0× 35 736
Ira Kogan-Sakin Israel 13 523 0.8× 261 1.1× 447 2.0× 131 1.1× 79 1.1× 13 869
Ursula Cesta Incani Italy 7 489 0.8× 188 0.8× 187 0.8× 106 0.9× 51 0.7× 9 703
Eva Schuster Austria 15 486 0.8× 281 1.2× 333 1.5× 87 0.7× 87 1.2× 37 867

Countries citing papers authored by Lu Yue

Since Specialization
Citations

This map shows the geographic impact of Lu Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Yue more than expected).

Fields of papers citing papers by Lu Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Yue. The network helps show where Lu Yue may publish in the future.

Co-authorship network of co-authors of Lu Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Yue. A scholar is included among the top collaborators of Lu Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Yue. Lu Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Mi, Gang Wang, Xutong Li, et al.. (2023). Evaluation of bladder filling effects on the dose distribution during radiotherapy for cervical cancer based on daily CT images. Journal of Applied Clinical Medical Physics. 24(11). e14097–e14097. 4 indexed citations
2.
Liu, Yang, et al.. (2022). LAG-3 is a promising inhibitory immune checkpoint for antitumor immunotherapy. Expert Review of Anticancer Therapy. 22(3). 289–296. 9 indexed citations
3.
Yue, Lu, et al.. (2021). Heterologous expression of Solanum tuberosum NAC1 gene confers enhanced tolerance to salt stress in transgenic Nicotiana benthamiana. Journal of Plant Biology. 64(6). 531–542. 5 indexed citations
4.
Wang, Gang, Xiwen Zhu, Fan Zhang, et al.. (2020). Applied research of a four-dimensional CT localization technique in radiotherapy and treatment planning for early lung cancer. Translational Cancer Research. 9(11). 7227–7235. 2 indexed citations
5.
Zhang, Jingfang, et al.. (2017). Rnf2 knockdown reduces cell viability and promotes cell cycle arrest in gastric cancer cells. Oncology Letters. 13(5). 3817–3822. 21 indexed citations
6.
Yue, Lu, Jinyu Xiang, Ping Sun, et al.. (2016). Relationship Between HSP70 and ERBB2 Expression in Breast Cancer Cell Lines Regarding Drug Resistance.. PubMed. 36(3). 1243–9. 8 indexed citations
7.
Shen, Zan, Chen Yao, Zifeng Wang, et al.. (2016). Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis. Molecular Therapy. 24(8). 1358–1368. 34 indexed citations
8.
Zhou, Fang, et al.. (2016). Both high expression of nucleophosmin/B23 and CRM1 predicts poorer prognosis in human gastric cancer. Apmis. 124(12). 1046–1053. 14 indexed citations
9.
Yue, Lu, et al.. (2016). INHIBITORY ACTIVITY OF MANGIFERIN ON HELICOBACTER PYLORI-INDUCED INFLAMMATION IN HUMAN GASTRIC CARCINOMA AGS CELLS. African Journal of Traditional Complementary and Alternative Medicines. 14(1). 263–271. 17 indexed citations
10.
Yao, Yasai, Wensheng Qiu, Ruyong Yao, et al.. (2015). miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression. Oncology Reports. 33(5). 2504–2512. 46 indexed citations
11.
Cong, Hui, Ruyong Yao, Zhenqing Sun, et al.. (2015). DNA hypermethylation of the vimentin gene inversely correlates with vimentin expression in intestinal- and diffuse-type gastric cancer. Oncology Letters. 11(1). 842–848. 13 indexed citations
12.
Yao, Yasai, Ruyong Yao, Likun Zhuang, et al.. (2014). MOR1 Expression in Gastric Cancer: A Biomarker Associated With Poor Outcome. Clinical and Translational Science. 8(2). 137–142. 30 indexed citations
13.
Wang, Xu, Gening Jiang, Ze Li, et al.. (2014). Computed tomography-guided iodine-125 interstitial implantation as an alternative treatment option for lung cancer. Indian Journal of Cancer. 51(6). 9–9. 15 indexed citations
14.
Lv, Hongying, Xiaoli Shi, Yasai Yao, et al.. (2014). Genetic polymorphism of GSTP1 and ERCC1 correlated with response to platinum-based chemotherapy in non-small cell lung cancer. Medical Oncology. 31(8). 86–86. 29 indexed citations
15.
Xiang, Jinyu, Wensheng Qiu, Xingang Wang, et al.. (2013). Efficient downregulation of ErbB-2 induces TACC1 upregulation in breast cancer cell lines. Oncology Reports. 29(4). 1517–1523. 4 indexed citations
16.
Zhou, Fang, Wensheng Qiu, Ruyong Yao, et al.. (2013). CRM1 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas. Medical Oncology. 30(4). 726–726. 54 indexed citations
17.
Ding, Aiping, Wenwen Zhao, Xiaoli Shi, et al.. (2013). Impact of NPM, TFF3 and TACC1 on the Prognosis of Patients with Primary Gastric Cancer. PLoS ONE. 8(12). e82136–e82136. 23 indexed citations
18.
Yue, Lu, Ying Wang, Huamao Wang, et al.. (2012). Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody. Oncology Reports. 28(4). 1453–1460. 12 indexed citations
19.
Yue, Lu, et al.. (2006). Design of a Novel Plasminogen Activator Based on the Structure of Hirudin. Acta Biochimica et Biophysica Sinica. 38(8). 531–536. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ines Koch Breakdown of academic impact, for papers by Youngtae Jeong Breakdown of academic impact, for papers by Suihai Wang Breakdown of academic impact, for papers by Wan-Ju Kim Breakdown of academic impact, for papers by Yueling Liao Breakdown of academic impact, for papers by Hannie Sietsma Breakdown of academic impact, for papers by Álvaro Gutiérrez-Uzquiza Breakdown of academic impact, for papers by Ira Kogan-Sakin Breakdown of academic impact, for papers by Ursula Cesta Incani Breakdown of academic impact, for papers by Eva Schuster
Rankless by CCL
2026